Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-07

FDA Approved: VIBATIV — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIBATIV (telavancin hydrochloride) submitted by Cumberland Pharmaceuticals Inc. The action updates the labeling and/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vibativ (telavancin)

Snippet

SUPPL AP for VIBATIV (TELAVANCIN HYDROCHLORIDE)